5 terminated. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Terminated 5 |
Follow Chronic Hepatitis B: new trials by email Literature Review of Chronic Hepatitis B trials Research Report on Chronic Hepatitis B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection Telbivudine, Placebo - Chronic Hepatitis B | Phase 3 | Terminated | Novartis Pharmaceuticals | 53 | 2014-10-31 | 2019-09-10 |
| Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma Tenofovir, Placebo - Chronic Hepatitis B, Hepatocellular Carcinoma | Phase 3 | Terminated | Taichung Veterans General Hospital | 320 | 2012-09-01 | 2014-09-04 |
| Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα Entecavir, Placebo - Chronic Hepatitis B, Rheumatoid Arthritis | Phase 3 | Terminated | Seoul National University Hospital | 43 | 2012-09-01 | 2017-03-06 |
| A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection Entecavir + Tenofovir, Adefovir + continuing Lamivudine - Chronic Hepatitis B | Phase 3 | Terminated | Bristol-Myers Squibb | 4 | 2008-08-01 | 2010-11-23 |
| Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients pegylated interferon alfa-2a, tenofovir DF / emtricitabine combination therapy, pegIFN / TDF / FTC combination therapy - Chronic Hepatitis B, HIV Infections | Phase 3 | Terminated | University Hospital, Bonn | 2 | 2004-09-01 | 2009-02-18 |
Hepatitis B, Chronic (5) · Acquired Immunodeficiency Syndrome (1) · Arthritis, Juvenile (1) · Arthritis, Psoriatic (1) · Arthritis, Rheumatoid (1) · Carcinoma, Hepatocellular (1) · HIV Infections (1) · Hepatitis B (1) · Spondylitis, Ankylosing (1)
Blood-Borne Infections (5) · Chronic Disease (5) · Communicable Diseases (5) · DNA Virus Infections (5) · Digestive System Diseases (5) · Disease Attributes (5) · Hepadnaviridae Infections (5) · Hepatitis (5) · Hepatitis, Chronic (5) · Hepatitis, Viral, Human (5) · Infections (5) · Liver Diseases (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Virus Diseases (5)
Tenofovir (3) · entecavir (2) · Telbivudine (1) · adefovir (1) · peginterferon alfa-2a (1)
Bristol-Myers Squibb (1) · Novartis Pharmaceuticals (1) · Seoul National University Hospital (1) · Taichung Veterans General Hospital (1) · University Hospital, Bonn (1)
Germany (2) · South Korea (2) · Turkey (Türkiye) (2) · Belgium (1) · Bulgaria (1) · Greece (1) · Israel (1) · Italy (1) · Poland (1) · Romania (1) · Taiwan (1) · Ukraine (1) · United States (1)